605 related articles for article (PubMed ID: 9827368)
21. Combination chemotherapy with carboplatin, cyclophosphamide and fluorouracil in advanced breast cancer.
Closon MT; Verbeke L; Kains JP; Tijtgat J; Schallier D
Anticancer Res; 1995; 15(2):591-5. PubMed ID: 7539240
[TBL] [Abstract][Full Text] [Related]
22. [Phase II trial as 2nd line chemotherapy with 5 fluorouracil and cisplatin (5FU-CDDP) for advanced breast cancer].
Fumoleau P; Bastit P; Horner D; Chauvergne J; Metz R; Bugat R; Cappelaere P
Bull Cancer; 1990; 77(8):805-10. PubMed ID: 2207369
[TBL] [Abstract][Full Text] [Related]
23. A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: preliminary results. Taxol Investigational Trials Group, Australia/New Zealand.
Bishop JF; Dewar J; Toner G; Tattersall MH; Olver I; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E; Levi J; Stephenson J
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-5-S17-9. PubMed ID: 9374084
[TBL] [Abstract][Full Text] [Related]
24. Vinorelbine (Navelbine) in the treatment of breast cancer: the European experience.
Fumoleau P; Delozier T; Extra JM; Canobbio L; Delgado FM; Hurteloup P
Semin Oncol; 1995 Apr; 22(2 Suppl 5):22-8; discussion 28-9. PubMed ID: 7740332
[TBL] [Abstract][Full Text] [Related]
25. Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer.
Chu L; Sutton LM; Peterson BL; Havlin KA; Winer EP
J Infus Chemother; 1996; 6(4):211-6. PubMed ID: 9229318
[TBL] [Abstract][Full Text] [Related]
26. Treatment of metastatic breast cancer by navelbine, mitoxantrone and continuous infusion 5-fluorouracil (FMN regimen): results of a pilot study.
Azim HA
J Infus Chemother; 1996; 6(2):102-6. PubMed ID: 8809659
[TBL] [Abstract][Full Text] [Related]
27. Treatment of advanced and relapsing breast cancer with a combination of paclitaxel and mitoxantrone. South-Central Hellenic Oncology Group.
Panagos GE
Semin Oncol; 1997 Feb; 24(1 Suppl 3):S17-21. PubMed ID: 9071335
[TBL] [Abstract][Full Text] [Related]
28. Epirubicin versus mitoxantrone in combination chemotherapy for metastatic breast cancer.
Pavesi L; Preti P; Da Prada G; Pedrazzoli P; Poggi G; Robustelli della Cuna G
Anticancer Res; 1995; 15(2):495-501. PubMed ID: 7763029
[TBL] [Abstract][Full Text] [Related]
29. [A comparative study of 4 sequential first-line chemotherapy protocols in locally advanced breast cancer].
Ferrero JM; Namer M; Dufour JF; Largillier R; Creisson A; Teissier E; Machiavello JC; Lallement M; Monticelli J; Abbes M
Bull Cancer; 1997 Jan; 84(1):10-6. PubMed ID: 9180853
[TBL] [Abstract][Full Text] [Related]
30. A phase II trial of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisolone rapidly alternating with doxorubicin and vincristine (CMFP/AV) in advanced breast cancer.
Rischin D; Bishop JF; Olver IN; Laidlaw CR; Zimet A; Jeal P; Dipell JF
Am J Clin Oncol; 1992 Oct; 15(5):392-4. PubMed ID: 1524039
[TBL] [Abstract][Full Text] [Related]
31. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
Klaassen U; Wilke H; Seeber S
J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323
[TBL] [Abstract][Full Text] [Related]
32. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
[TBL] [Abstract][Full Text] [Related]
33. First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study.
Pectasides D; Dimopoulos MA; Aravantinos G; Kalophonos HP; Papacostas P; Briasoulis E; Cogas E; Papadimitriou C; Skarlos D; Kosmidis P; Fountzilas G
Anticancer Res; 2001; 21(5):3575-80. PubMed ID: 11848526
[TBL] [Abstract][Full Text] [Related]
34. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.
Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D
Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837
[TBL] [Abstract][Full Text] [Related]
35. Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642).
Costanza ME; Berry D; Henderson IC; Ratain MJ; Wu K; Shapiro C; Duggan D; Kalra J; Berkowitz I; Lyss AP
Clin Cancer Res; 1995 Jul; 1(7):699-704. PubMed ID: 9816035
[TBL] [Abstract][Full Text] [Related]
36. Mitoxantrone combined with vincristine, cyclophosphamide and fluorouracil for advanced breast cancer. A study of short-term response rate.
Misset JL; Metz R; Gil-Delgado M; Keiling R; Cappelaere P; Armand JP; Prévot G; Grimbert J; Mathé G; Hibberd M
Anticancer Res; 1987; 7(4B):737-40. PubMed ID: 3674760
[TBL] [Abstract][Full Text] [Related]
37. Randomized trial comparing conventional intravenous bolus FEC and FEC with high-dose infusional 5-fluorouracil as first-line treatment of advanced breast cancer.
Hebbar M; Bonneterre J; Fournier C; Vanlemmens L; Pion JM; Adenis A; Kamus E; Hecquet B; Conroy T; Tubiana-Hulin M
J Infus Chemother; 1995; 5(4):201-5. PubMed ID: 8934728
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and toxicity of vinorelbine with doxorubicin/cyclophosphamide combination chemotherapy in a phase I-II study for advanced or recurrent breast cancer patients.
Saeki T; Takashima S; Ogita M; Tabei T; Adachi I; Tamura K; Takatsuka Y; Kanda K
Breast Cancer; 2006; 13(2):159-65. PubMed ID: 16755111
[TBL] [Abstract][Full Text] [Related]
39. A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer.
Finek J; Holubec L; Svoboda T; Sefrhansova L; Pavlikova I; Votavova M; Sediva M; Filip S; Kozevnikova R; Kormunda S
Anticancer Res; 2009 Feb; 29(2):667-70. PubMed ID: 19331218
[TBL] [Abstract][Full Text] [Related]
40. Combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in advanced breast carcinoma.
Dalley DN; Levi JA; Aroney RS
Med J Aust; 1980 Mar; 1(5):216-8. PubMed ID: 6990214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]